Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 61   

Articles published

TENX 3.21 +0.01 (0.31%)
price chart
Tenax Therapeutics to Present at Cowen & Company 35th Annual Health Care ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, ...
Tenax Therapeutics, Inc. Files SEC Form SC 13G, Statement of Acquisition of ...
By a News Reporter-Staff News Editor at Economics Week -- According to news reporting originating from Washington, D.C. , by VerticalNews journalists, a U.S.
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
MORRISVILLE, N.C., Sep 16, 2014 (BUSINESS WIRE) -- Oxygen Biotherapeutics, Inc. OXBT a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the ...
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Tenax Therapeutics' (TENX) CEO John Kelley on Q2 2015 Results - Earnings ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q2 2015 Results - Earnings Call Transcript. Dec. 17, 2014 1:19 PM ET | About: Tenax Therapeutics, Inc. (TENX) by: SA Transcripts. Tenax Therapeutics Inc. (NASDAQ:TENX). Q2 2015 Earnings Conference ...
Related articles »  
Form 4 TENAX THERAPEUTICS, INC. For: Feb 13 Filed by: Jebsen Michael B
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. Jebsen Michael B. (Last), (First), (Middle). 152 TOWNSEND DR. (Street). CLAYTON, NC, 27527 ...
UPDATE: MLV Initiates Coverage On Tenax Therapeutics
The United States Food and Drug Administration recently granted Fast Track status for levosimendan, and Tenax enrolled their first patient in the Phase III study in September.
Tenax Therapeutics Issues Employment Inducement Award With Appointment of ...
MORRISVILLE, N.C. - Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today confirmed Paula Bokesch, M.D.
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Stocks Underperform for the Week: Tenax Therapeutics Inc , BioLife Solutions Inc
Tenax Therapeutics Inc (NASDAQ:TENX) has lost 8.02% during the past week and dropped 13.94% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 9.48%.
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
MORRISVILLE, N.C., Sep 22, 2014 (BUSINESS WIRE) -- Tenax Therapeutics, Inc. TENX, -1.56% formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical ...
Morrisville's Tenax studies experimental drug in cardiac surgery patients  Triangle Business Journal
Related articles »